NANOG and cancer: Strong experimental and correlative clinical evidence suggests that NANOG (NANOG or NP8) is expressed in subpopulations of cancer cells and has functional roles in mediating CSC properties, cell motility and invasion, therapy resistance, and metastasis [1, 3,5,6,7,8,9,27, 28,29].